Veterinary pharmacy pushes closer to specialty recognition
CURRENT BRIEF VERSION: Veterinary pharmacy is moving closer to formal specialty recognition, and that’s the core question behind Clinician’s Brief’s recent Veterinary Breakroom discussion: should the field become a specialty? The broader backdrop is no longer hypothetical. The Board of Pharmacy Specialties issued a call in February 2025 to evaluate veterinary pharmacy as a potential board-certified specialty, and the American College of Veterinary Pharmacists said in February 2026 that a public comment period had opened, with comments due April 1, 2026. The push comes as more pet prescriptions are filled outside veterinary hospitals, while pharmacists, veterinarians, and educators continue to point to major training gaps in species-specific dosing, toxicities, compounding, and legal requirements. Clinician’s Brief’s broader Breakroom coverage has also underscored why this matters now: veterinary medicine is simultaneously grappling with access-to-care gaps, rising economic pressure on new graduates, fast-moving therapeutics like monoclonal antibodies, and antimicrobial stewardship questions such as delayed “wait-and-see” prescribing—all trends that make medication expertise and cross-professional coordination more consequential in everyday practice. (pharmacytimes.com)
Why it matters: For veterinary professionals, the debate isn’t just about credentials. It’s about medication safety, workflow, and trust across the care team. Multiple reports and commentaries have described pharmacists receiving little formal veterinary pharmacology training, with resulting friction over dose verification, substitutions, and counseling. In one Pennsylvania survey cited by dvm360, 73% of veterinarians said a pharmacist had questioned a prescribed strength or dose, and published examples included serious patient harm tied to inappropriate dose changes. At the same time, practices are being asked to deliver safe care in a more complex environment—balancing client cost concerns, stewardship, new biologics, and uneven access to veterinary services. A recognized specialty could help standardize training and create clearer pathways for collaboration, especially as practices rely more on community pharmacies, compounding partners, and complex pharmacotherapy. (dvm360.com)
What to watch: Watch whether specialty recognition advances after the current comment and petition process, and whether that leads to clearer standards for training, certification, and pharmacist-veterinarian collaboration. It will also be worth watching whether the conversation expands beyond credentialing alone to include how veterinary teams manage access, affordability, antimicrobial stewardship, and newer drug classes that demand more specialized medication knowledge. (vetmeds.org)